financetom
Business
financetom
/
Business
/
BP says weak refining margins to dent Q3 profit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BP says weak refining margins to dent Q3 profit
Oct 11, 2024 12:50 AM

LONDON, Oct 11 (Reuters) -

Weak refining margins due to a slowdown in global demand for

fuel and lower oil trading results will dent BP's

third-quarter profit by up to $600 million, the British oil

major said on Friday.

Global oil refiners are facing a drop in profitability to

multi-year lows, marking a downturn for an industry that had

enjoyed surging returns post-pandemic and underlining the extent

of the current demand slowdown.

BP's second-quarter underlying replacement cost profit, the

company's definition of net income, was $2.756 billion.

Rival Shell on Monday also warned of slump in

refining profit margins and weak oil product trading in the

third quarter, while U.S. oil major Exxon Mobil ( XOM ) said

last week that a slump in oil prices was set to hit its

third-quarter profit.

Oil prices fell by 17% in the third quarter, the largest

quarterly decline in a year, on worries about the global oil

demand outlook. Brent futures settled at $71.77 a barrel

on the last trading day of the quarter.

BP's earnings snapshot comes as CEO Murray Auchincloss

scales back the firm's energy transition strategy to regain

investor confidence.

Auchincloss took the helm in January but has struggled

to stem the drop in BP's share price, which has underperformed

its rivals so far this year as investors question the company's

ability to generate profits under its current strategy.

Year-to-date, BP's stock has fallen almost 12%, while

shares of Shell and Exxon have gained nearly 1% and 23%,

respectively.

BP, which is set to post its quarterly results on Oct.

29, said its upstream production in the third quarter is

expected to be broadly unchanged from the prior three months.

In the second quarter, BP's total hydrocarbons

production stood at 899,000 barrels of oil equivalent per day

(mboe/d).

The London-listed company said in the oil production and

operations unit, the third-quarter result will be impacted by

$100 million to $300 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved